跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,453 条关于
“Bi-Targeted Antibody Cytotoxicity”
全部
25,453
临床试验
10,078
药物
3,072
机构
102
资讯
12,201
去年
VERAXA Biotech and Voyager Acquisition to Merge, Creating $1.64B NASDAQ-Listed Cancer Therapeutics Company
上个月
Elephas Demonstrates elive™ Platform Measures Cytotoxicity in Targeted Therapies, Expanding Functional Precision Medicine Reach
去年
BioInvent Advances BI-1910 Anti-TNFR2 Antibody with Population Modeling Data at PAGE 2025
去年
BioInvent's BI-1910 Shows Promise in Phase 1 Solid Tumor Trial
去年
China Approves Zanidatamab as First Dual HER2-Targeted Bispecific Antibody for Biliary Tract Cancer
去年
Fermented Stevia Extract Shows Selective Cytotoxicity Against Pancreatic Cancer Cells in Laboratory Study
去年
Novel Therapies Show Promise in Melanoma, Breast, and Prostate Cancers
去年
HS-20093 (GSK'227) Receives FDA and EMA Designations for Osteosarcoma and SCLC
8个月前
BioInvent's BI-1808 Plus Pembrolizumab Shows 24% Response Rate in Recurrent Ovarian Cancer
去年
FDA Grants Fast Track Designation to BioInvent's BI-1808 for Cutaneous T-cell Lymphoma
第 1 页，共 1221 页
上一页
下一页
